Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial

BACKGROUND: Baloxavir marboxil has demonstrated safety and efficacy in treating adult and adolescent outpatients with acute influenza (CAPSTONE-1 trial). Here, we report a subgroup analysis of outcomes in adolescents from the trial. METHODS: CAPSTONE-1 was a randomized, double-blind, placebo-control...

Descripción completa

Detalles Bibliográficos
Autores principales: Portsmouth, Simon, Hayden, Frederick G, Kawaguchi, Keiko, Ishibashi, Toru, Kinoshita, Masahiro, Shishido, Takao, Tsuchiya, Kenji, Uehara, Takeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087144/
https://www.ncbi.nlm.nih.gov/pubmed/33340316
http://dx.doi.org/10.1093/jpids/piaa145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087144/
https://www.ncbi.nlm.nih.gov/pubmed/33340316
http://dx.doi.org/10.1093/jpids/piaa145

Ejemplares similares